FDA Drug Application (021332) for SYMLIN by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number021332
Product Number001
FormINJECTABLE;SUBCUTANEOUS
DosageEQ 3MG BASE/5ML (EQ 600MCG BASE/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSYMLIN
Active IngredientPRAMLINTIDE ACETATE



Back to FDA Applications sponsored by ASTRAZENECA AB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.